Rupert Vessey's Net Worth
$29.3 Million
Who is Rupert Vessey?
Rupert Vessey has an estimated net worth of $29.3 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, BIO-TECHNE Corp, CELGENE CORP /DE/, and Juno Therapeutics, Inc..
SEC CIK
Rupert Vessey's CIK is 0001677618
Past Insider Trading and Trends
2019 was Rupert Vessey's most active year for acquiring shares with 43 total transactions. Rupert Vessey's most active month to acquire stocks was the month of October. 2021 was Rupert Vessey's most active year for disposing of shares, totalling 30 transactions. Rupert Vessey's most active month to dispose stocks was the month of October. 2020 saw Rupert Vessey paying a total of $7,404,338.65 for 337,572 shares, this is the most they've acquired in one year. In 2021 Rupert Vessey cashed out on 490,445 shares for a total of $16,980,471.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6
EVP & President, Research
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -51.34% | -50.38K |
$67.06 | -$3,378,818.10 | 47.75K |
May 3
| |||
Form 4
| +59.90% | 36.76K |
$65.71 | -$2,529,703.58 | 98.14K |
Mar 10
| |||
Form 4
| +7.52% | 4.29K |
$81.13 | -$364,922.74 | 61.37K |
Dec 2
| |||
Form 4
| +13.29% | 6.69K |
$68.60 | -$553,851.85 | 57.08K |
Nov 7
| |||
Form 4
| -35.10% | -27.25K |
$63.13 | -$2,466,360.66 | 50.38K |
Mar 16
| |||
Form 4
| +12.06% | 8.36K |
$68.42 | -$598,743.42 | 77.64K |
Mar 10
| |||
Form 4
| +23.20% | 13.05K |
$68.63 | -$707,094.89 | 69.28K |
Mar 1
| |||
Form 4
| +4.23% | 2.28K |
$64.99 | -$85,266.88 | 56.24K |
Feb 4
| |||
Form 4
| +68.82% | 22K |
$62.35 | -$1,436,107.55 | 53.96K |
Dec 31
| |||
Form 4
| -37.65% | -19.30K |
$61.99 | -$1,196,252.03 | 31.96K |
Dec 16
| |||
Form 4
| +9.14% | 4.29K |
$55.41 | -$249,234.18 | 51.26K |
Dec 2
| |||
Form 4
| -13.65% | -7.43K |
$63.28 | -$1,952,045.96 | 46.96K |
Jul 30
| |||
Form 4
| +20.49% | 9.25K |
$64.44 | -$515,133.36 | 54.39K |
May 8
| |||
Form 4
| -40.36% | -30.55K |
$64.29 | -$1,963,802.34 | 45.14K |
May 5
| |||
Form 4
| +5.66% | 4.06K |
$60.93 | -$213,559.65 | 75.69K |
Mar 10
| |||
Form 4
| +25.17% | 14.4K |
$61.63 | -$551,218.72 | 71.63K |
Mar 1
| |||
Form 4
| +4.39% | 2.41K |
$61.56 | -$73,010.16 | 57.22K |
Feb 4
| |||
Form 4
| +29.87% | 12.61K |
$62.03 | -$822,331.71 | 54.82K |
Dec 31
| |||
Form 4
| +11.30% | 4.29K |
$62.18 | -$280,183.08 | 42.21K |
Dec 2
| |||
Form 4
| -26.14% | -13.42K |
$61.34 | -$823,244.14 | 37.92K |
Nov 23
| |||
Form 4
| -9.48% | -5.38K |
$55.29 | -$957,382.74 | 51.34K |
Nov 19
| |||
Form 4
| +5.48% | 2.94K |
$58.45 | -$167,108.55 | 56.72K |
Oct 30
| |||
Form 4
| +11.24% | 5.43K |
$60.26 | -$317,811.24 | 53.78K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +23.38% | 9.16K |
$56.14 | -$276,769.80 | 48.34K |
Mar 2
| |||
Form 4
| +58.27% | 14.43K |
$59.06 | -$526,992.38 | 39.18K |
Mar 1
| |||
Form 4
| +10.88% | 2.43K |
$64.29 | -$74,769.27 | 24.76K |
Feb 4
| |||
Form 4/A
| +57.48% | 8.15K |
$64.19 | -$507,742.90 | 22.33K |
Dec 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
| +55.37% | 8.15K |
$64.19 | -$507,742.90 | 22.87K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
∞
| 14.79K |
—
|
—
| 14.79K |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIO-TECHNE Corp (TECH) Snapshot price: $71.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.54% | 1.46K |
—
|
—
| 9.35K |
Oct 24
| |||
Form 4
| +25.96% | 1.63K |
—
|
—
| 7.88K |
Oct 26
| |||
Form 4
| +27.55% | 338 |
—
|
—
| 1.56K |
Oct 27
| |||
Form 4
| +18.78% | 194 |
—
|
—
| 1.23K |
Oct 28
| |||
Form 4
| +60.90% | 391 |
—
|
—
| 1.03K |
Oct 29
| |||
Form 4
| +336.73% | 495 |
—
|
—
| 642 |
Oct 24
| |||
Form 4
|
∞
| 147 |
—
|
—
| 147 |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CELGENE CORP /DE/ No price found
PRES., RESEARCH AND EARLY DEV.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.79K |
—
|
—
|
0
|
Nov 20
| |||
Form 4
| +23.79% | 2.73K |
$108.03 | -$285,631.32 | 14.18K |
Oct 31
| |||
Form 4
| +57.91% | 4.2K |
$95.21 | -$240,976.51 | 11.45K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +59.86% | 2.72K |
$68.20 | -$179,638.80 | 7.25K |
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
| +53.80% | 1.59K |
$86.89 | -$133,636.82 | 4.54K |
May 4
| |||
Form 4
|
∞
| 2.95K |
$99.80 | -$266,765.40 | 2.95K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
| -100.00% | -778.00 |
$112.17 | -$157,679.94 |
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| -83.72% | -4.00K |
$124.42 | -$497,672.00 | 778 |
Mar 1
| |||
Form 4
| +315.48% | 3.63K |
$115.54 | -$230,502.30 | 4.78K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
| -68.49% | -2.50K |
$123.18 | -$307,950.00 | 1.15K |
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Juno Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |